525-47-3 Usage
Uses
Used in Organic Synthesis:
5-Nitroquinoline-2-carboxylic acid is used as a key intermediate for the synthesis of various heterocyclic and pharmaceutical compounds. Its nitro group allows for a range of chemical reactions, facilitating the creation of diverse organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 5-nitroquinoline-2-carboxylic acid is utilized as a starting material for the development of new drugs. Its unique structure and reactivity make it a promising candidate for the design of innovative therapeutic agents.
Used in Antibacterial Agents:
5-Nitroquinoline-2-carboxylic acid has been researched for its potential as an antibacterial agent. It demonstrates the ability to inhibit bacterial DNA gyrase, a crucial enzyme for bacterial DNA replication, thus showing promise in the development of new antibiotics to combat resistant bacterial strains.
Check Digit Verification of cas no
The CAS Registry Mumber 525-47-3 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,2 and 5 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 525-47:
(5*5)+(4*2)+(3*5)+(2*4)+(1*7)=63
63 % 10 = 3
So 525-47-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H6N2O4/c13-10(14)8-5-4-6-7(11-8)2-1-3-9(6)12(15)16/h1-5H,(H,13,14)
525-47-3Relevant academic research and scientific papers
Carbapenem antibiotic compounds
-
, (2008/06/13)
The present invention relates to carbapenems and provides a compound of the formula (I) STR1 wherein: R1 is 1-hydroxyethyl, 1-fluoroethyl or hydroxymethyl; R2 is hydrogen or C1-4 alkyl; R3 is hydrogen or C1-4 alkyl; P1 is of the formula: STR2 and one or two of A,B,C,D,E,F,G and H, are nitrogen and the remainder are CH; and P is bonded to the nitrogen of the linking carbamoyl group by a carbon atom, in either ring, is substituted by the carboxy group on a carbon atom, in either ring, and is optionally further substituted, by up to three substitutents, on a carbon atom, in either ring; or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof. Processes for their preparation, intermediates in their preparation, their use as therapeutic agents and pharmaceutical compositions containing them are also described.
